TSX closed
Loading markets…

Advertisement

PARTNER SPOTLIGHT

CIBC Investor's Edge

Get 200 free trades when you open an eligible CIBC Investor's Edge account.

  • 200 free stock & ETF trades
  • Unlimited commission-free trades on 180+ select ETFs
  • Offer ends September 30, 2026
Stocks/NASDAQ/TECX

Tectonic Therapeutic, Inc. (TECX : NASDAQ)

Common Stock

$27.91

USD

+0.00 (%)

Last updated: 2026-09-17

Get TECX alerts:

TECX

Tectonic Therapeutic, Inc.

Source:WealthAwesomeWealthAwesome
$3.01 (-9.96%)
30 day period
$27.21$32.46$37.71Aug 6Aug 27Sep 17

Performance

1 Day

-2.10%

1 Week

-8.43%

1 Month

-17.55%

YTD

-7.15%

Key Statistics

Market Cap

$545.62M

52W High

$39.53

52W Low

$14.38

P/E Ratio

-

50 Day MA

$32.42

200 Day MA

$27.67

Beta

0.22

Dividend Yield

-

Advertisement

Technical Indicators

Price vs 50-Day SMA

Below 50 SMA

Price vs 200-Day SMA

Above 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
9/17/2026$28.15$28.71$27.11$27.21$27.21186,688
9/16/2026$28.50$29.23$27.68$27.91$27.91187,414
9/15/2026$29.71$30.02$27.95$28.51$28.51220,901
9/14/2026$29.39$30.73$29.38$29.71$29.71145,004
9/11/2026$29.03$29.39$28.56$29.05$29.05154,980
9/10/2026$30.06$30.32$28.40$28.61$28.61252,400
9/9/2026$30.18$31.00$29.81$30.48$30.48133,400
9/8/2026$30.32$31.41$29.96$30.40$30.40116,600
9/4/2026$29.85$31.12$29.74$30.75$30.75159,300
9/3/2026$30.68$32.52$29.45$29.92$29.92140,400

Analyst Price Targets

Based on 6 analysts covering TECX · as of Sep 17, 2026

📈

Wall Street analysts forecast TECX stock price to rise 177.9% over the next 12 months.

Consensus

Strong Buy

4.83 / 5.00

Avg. Target

US$77.56

+177.9% Upside

Current Price

US$27.91

Last close

Analyst Breakdown (6 analysts)

Strong Buy 5
Buy 1
Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on TECX's historical volatility

HistoricalForecast68%95%
US$7.72US$19.66US$31.60US$43.54US$55.49US$67.43TodayJun 17Aug 4Sep 17Oct 30Dec 13Jan 25

30-Day Vol

88.1%

Annualized

90-Day Vol

77.3%

Annualized

Trend (90d)

-49.2%

Annualized drift

90d Mean

US$22.83

Expected price

HorizonExpected68% Range (1σ)
30 trading daysUS$25.66US$18.93US$34.78
60 trading daysUS$24.20US$15.74US$37.21
90 trading daysUS$22.83US$13.48US$38.66

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Tectonic Therapeutic, Inc.

Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts.

Financials

Revenue (TTM)
$0
EBITDA
$-93.66M
Profit Margin
0.00%
ROE (TTM)
-33.80%
EPS (Diluted)
-4.46
Book Value
12.24

Classification

Sector
Health Care
Industry
Biotechnology
Group
Pharmaceuticals, Biotechnology & Life Sciences

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About TECX.US

Market movers

Recent NASDAQ movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
DLXYDelixy Holdings Limited Ordinary Shares$2.29+451.81%
MEDSDataMEDS AI, Inc.$6.07+274.69%
SNYRSynergy CHC Corp. Common Stock$0.27+234.15%
QCLSQ/C Technologies, Inc.$0.96+118.45%
AEHLAntelope Enterprise Holdings Ltd$9.22+78.68%
ZTGZenta Group Company Limited$1.18+75.33%
PDSBPDS Biotechnology Corp$0.99+69.25%
TPSTTempest Therapeutics Inc$1.21+60.18%

Advertisement